Global health body says it is sifting the wheat from the chaff in order to save lives – but critics fear it is pandering to ...

A conserved signaling axis linking Drosophila adipose tissue to nephrocyte function reveals how obesity can drive kidney dysfunction and points to new opportunities for therapeutic intervention.

Drug discovery is a lengthy and expensive process; however, computational modeling and AI now offer unprecedented opportunities for faster discovery. A field still in urgent need of new treatments, ...

CAMBRIDGE, Mass. & LONDON--(BUSINESS WIRE)--Valink Therapeutics (“Valink”), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates ...

CAMBRIDGE, Mass., Dec. 17, 2025 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company providing integrated solutions for biological drug discovery and development from "Idea to IND ...

Chronic kidney disease (CKD) is a progressive condition that begins with tissue damage and gradually leads to loss of kidney function. The condition, which affects about 10% of the global population, ...

Addition Therapeutics has emerged from stealth with $100 million in hand to develop new types of gene therapies that might work against rare as well as chronic diseases. Spun out of research at the ...

Lunit and Daiichi Sankyo collaborate to integrate AI-powered digital pathology for biomarker discovery in oncology programs, enhancing translational research and patient stratification. Lunit SCOPE ...